NOCTILUCA S.A. ZY -15 (G0Z) - Total Liabilities
Based on the latest financial reports, NOCTILUCA S.A. ZY -15 (G0Z) has total liabilities worth €1.55 Million EUR (≈ $1.81 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NOCTILUCA S.A. ZY -15 (G0Z) equity growth momentum to track the company's year-over-year net asset growth rate.
NOCTILUCA S.A. ZY -15 - Total Liabilities Trend (2021–2024)
This chart illustrates how NOCTILUCA S.A. ZY -15's total liabilities have evolved over time, based on quarterly financial data.
NOCTILUCA S.A. ZY -15 Competitors by Total Liabilities
The table below lists competitors of NOCTILUCA S.A. ZY -15 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CHINA MAPLE LE.ED.HD0005
F:CML1
|
Germany | €4.59 Billion |
|
Elutia Inc.
NASDAQ:ELUT
|
USA | $34.68 Million |
|
HCL Infosystems Limited
NSE:HCL-INSYS
|
India | Rs7.37 Billion |
|
I-Hwa Industrial Co Ltd
TW:1456
|
Taiwan | NT$11.45 Billion |
|
SINCLAIRS HOTELS ORD (BSE)
NSE:SINCLAIR
|
India | Rs486.55 Million |
|
Kriti Nutrients Limited
NSE:KRITINUT
|
India | Rs435.96 Million |
|
TAPEX INC
KO:055490
|
Korea | ₩39.20 Billion |
|
SG Choongbang Co Ltd
KO:001380
|
Korea | ₩44.00 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down NOCTILUCA S.A. ZY -15's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NOCTILUCA S.A. ZY -15 market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NOCTILUCA S.A. ZY -15's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NOCTILUCA S.A. ZY -15 (2021–2024)
The table below shows the annual total liabilities of NOCTILUCA S.A. ZY -15 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €3.09 Million ≈ $3.61 Million |
+140.79% |
| 2023-12-31 | €1.28 Million ≈ $1.50 Million |
-29.06% |
| 2022-12-31 | €1.81 Million ≈ $2.11 Million |
+14.07% |
| 2021-12-31 | €1.59 Million ≈ $1.85 Million |
-- |
About NOCTILUCA S.A. ZY -15
NOCTILUCA SPÓLKA AKCYJNA develops, produces, and sells OLED emitter material chemical compounds. Its products are used in monitors, TVs, smartphones, wearables, or VR devices. The company is headquartered in Torun, Poland.